Header Logo

Connection

Anne Coleman to Ipilimumab

Back to Details
This is a "connection" page, showing publications Anne Coleman has written about Ipilimumab.
Anne Coleman
Connection Strength
0.176
Ipilimumab
  1. Ophthalmic Immune-Related Adverse Events after Anti-CTLA-4 or PD-1 Therapy Recorded in the American Academy of Ophthalmology Intelligent Research in Sight Registry. Ophthalmology. 2021 06; 128(6):910-919.
    View in: PubMed
    Score: 0.176
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.